Keeping readers informed of the latest research results in the fields of oncology and immunology has always been one of the main services provided by "Cancer Immunology, Immunotherapy". To make this service even more comprehensive, the scope of the journal was expanded some years ago to include more of the progress being made in the various fields of biology concerned with biological response modifiers, thus enabling readers to keep up to date on the latest advances in our understanding of tumor-host interactions.

Tumor immunologists, clinical oncologists, virologists, and medical microbiologists involved in the development of methods of treatment and therapies for cancer patients will have access to the information contained in this journal. The journal publishes short editorials (including "position papers"), general reviews, original articles, and short communications, providing a forum for the most recent experimental and clinical advances in tumor immunology.

This journal is included in the ADONIS service. In the ADONIS service copies of individual articles can be printed out from compact discs (CD-ROM) on demand. An explanatory leaflet giving further details of the scheme is available from the publishers on request.